Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect?-Reference-Cited by-同舟云学术

Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect?

Published:2002-09 Issue:3 Volume:330 Page:251-254
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Schmidt Werner J.,Mayerhofer Andreas,Meyer Anja,Kovar Karl-A.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference22 articles.

1. Sterochemical studies on medicinal agents. 15;Bell;Absolute configurations and analgetic potencies of enantiomeric diastereomers of 3-allyl-1- methyl-4-phenyl-4-propionoxypiperidine, J. Med. Chem.,1973

2. Büchler, J., Stereoselektive Gewinnung, Analytik und Pharmakokinetik der Enantiomere des Ecstasy-Analogons N-Ethyl-3,4-methylendioxyamphetamin (MDE) und seiner Metabolite. (2000) Fakultät für Chemie und Pharmazie der Universität Tübingen, Germany. (PhD-Thesis)

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early onset Parkinson’s disease in the cycle of 3,4-methylenedioxymethamphetamine and substance use: a case report;Journal of Medical Case Reports;2023-09-23

2. Haloperidol‐induced catalepsy as an animal model for parkinsonism: A systematic review of experimental studies;European Journal of Neuroscience;2021-04-25

3. 8-Propyl-6H-[1,3]dioxolo[4,5-g]chromen-6-one: A new coumarin with monoamine oxidase B inhibitory activity and possible anti-parkinsonian effects;Brazilian Journal of Pharmaceutical Sciences;2020

4. Coumarin analogue 3-methyl-7H-furo[3,2-g] chromen-7-one as a possible antiparkinsonian agent;Biomédica;2019-09-01

5. Drugs of abuse and Parkinson's disease;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2016-01